(NASDAQ: MASI) Masimo's forecast annual revenue growth rate of 1.22% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.13%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.67%.
Masimo's revenue in 2025 is $1,715,100,000.On average, 12 Wall Street analysts forecast MASI's revenue for 2025 to be $83,310,334,899, with the lowest MASI revenue forecast at $79,980,070,061, and the highest MASI revenue forecast at $85,942,318,400. On average, 12 Wall Street analysts forecast MASI's revenue for 2026 to be $89,004,013,493, with the lowest MASI revenue forecast at $85,029,181,267, and the highest MASI revenue forecast at $91,958,280,688.
In 2027, MASI is forecast to generate $95,718,257,118 in revenue, with the lowest revenue forecast at $90,991,429,606 and the highest revenue forecast at $99,370,805,650.